Phacilitate Leaders World 

Avoid Tripping at the Last Mile

Avoid Tripping at the Last Mile

Your therapy is cryopreserved and ready to change a patient's life. Is the cryogenic ecosystem in place to ensure you do not trip at the last mile?

Modern medicine is evolving to support the advent of cellular-based therapies and treatments. These therapies provide new promise and opportunity to so many patients. However, cellular-based therapies have specific handling requirements related to temperature.

In this case, shelf-life is only preserved when the temperature can be maintained below the glass transition of water (Tg). Any increase in temperature can result in unintended damage to cellular products. Whether you are handling vitrified eggs and embryos, or you are handling a blockbuster in CAR-T, your cryogenic eco-system needs to be rock solid. 

Watch this webinar to gain perspective from two global leaders with decades of experience in handling inventories of high value, cryopreserved cellular products. 

Watch it on demand

WEBINAR: Avoid Tripping at the Last Mile

 

Details

Moderator:

David Lewandowski, Global Product Marketing Manager, Brooks Life Science Systems

Speakers:

Kaj Rydman, Vice President, Reproductive Operations, California Cryobank Life Sciences

Albert Ribickas, BMT/QC Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Watch it on demand

Get the latest industry insights and exclusive deals straight to your inbox

Get the latest industry insights and exclusive deals straight to your inbox